Catalyst Pharmaceuticals, Inc. (CPRX)
24.30
-0.12
(-0.51%)
USD |
NASDAQ |
Feb 20, 14:58
Catalyst Pharmaceuticals EPS Diluted (Quarterly) : 0.4153 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | 1.456 |
| United Therapeutics Corp. | 7.161 |
| Supernus Pharmaceuticals, Inc. | -0.7978 |
| Karyopharm Therapeutics, Inc. | -5.708 |
| Krystal Biotech, Inc. | 1.699 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 52.78M |
| Revenue (Quarterly) | 148.39M |
| Total Expenses (Quarterly) | 95.61M |
| Enterprise Value | 2.315B |
| Gross Profit Margin (Quarterly) | 78.44% |
| Profit Margin (Quarterly) | 35.57% |
| Earnings Yield | 7.05% |
| Operating Earnings Yield | 8.39% |
| Normalized Earnings Yield | 6.954 |